| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |